Advicenne S.A.
ADVIC.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.87M
Close$
Share Statistics
| Market cap | $63.87 Million |
|---|---|
| Enterprise Value | $83.50 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.43 |
| Outstanding Shares | 9,826,315 |
Return
| Return on Equity | 27.04% |
|---|---|
| Return on Assets | -77.47% |
| Return on Invested Capital | -535.60% |
Valuation & Multiples
| P/E Ratio | 221.16 |
|---|---|
| PEG | -114.5 |
| Price to Sales | 6.5 |
| Price to Book Ratio | -2.17 |
| Enterprise Value to Revenue | 6.84 |
| Enterprise Value to EBIT | 42.36 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | -0.98 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Advicenne S.A.
11 employees
CEO: Didier Laurens Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal r...